| Name | Title | Contact Details |
|---|
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
Vesta Healthcare is an industry-leading technology and clinical services organization, dedicated to connecting caregiver insights to the rest of the care team.
Xcelience, LLC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Tampa, FL. To find more information about Xcelience, LLC, please visit www.xcelience.com
Since 1979, The MedTech Group, Inc., has been a leading full service contract manufacturer of medical devices and components. Operating under the guidelines of our ISO registrations, MedTech offers the healthcare industry production capabilities that are
Prevea Health Network is a Green Bay, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.